This powerful drug combo cuts prostate cancer deaths by 40%

Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%. Researchers tested a therapy that combines enzalutamide, an existing cancer drug, with standard hormone therapy. This approach significantly lowered death…

Read More

Even “diet” soda may be quietly damaging your liver, scientists warn

A large-scale investigation has found that people who regularly consume both sugar-sweetened beverages (SSBs) and low- or no-sugar-sweetened beverages (LNSSBs) face a significantly greater likelihood of developing metabolic dysfunction-associated steatotic liver disease (MASLD).1 Presented at UEG Week 2025, the research followed 123,788 adults from the UK Biobank who had no signs of liver disease at…

Read More